INTECH Investment Management’s Cogent Biosciences COGT Stock Holding History

INTECH Investment Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Buy	42,610 +280	+0.7%	+$9.8K	0.02%	789
2026 Q1	$1.63M	Sell	42,330 -19,260	-31%	-$711K	0.02%	786
2025 Q4	$2.19M	Buy	61,590 +23,311	+61%	+$655K	0.02%	698
2025 Q3	$550K	Sell	38,279 -17,138	-31%	-$203K	﹤0.01%	1527
2025 Q2	$398K	Sell	55,417 -1,788	-3%	-$9.91K	﹤0.01%	1734
2025 Q1	$343K	Buy	57,205 +548	+1%	+$4.3K	﹤0.01%	1811
2024 Q4	$442K	Buy	56,657 +28,233	+99%	+$281K	﹤0.01%	1632
2024 Q3	$307K	Buy	+28,424	New	+$277K	﹤0.01%	1508

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

INTECH Investment Management's COGT Position: Q2 2026 in Review

INTECH Investment Management increased its Cogent Biosciences (COGT) stake by 0.66% in Q2 2026, buying an estimated $9.8K and bringing the position to 42,610 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #789.

INTECH Investment Management first reported a position in COGT in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.19M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

INTECH Investment Management held 42,610 shares of Cogent Biosciences worth $1.65M as of Q2 2026.
INTECH Investment Management bought 280 Cogent Biosciences shares in Q2 2026, an estimated $9.8K.
Cogent Biosciences made up 0.02% of INTECH Investment Management's portfolio in Q2 2026, its #789 holding.
INTECH Investment Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Cogent Biosciences position peaked at $2.19M in Q4 2025.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.